Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 32126 - 32150 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	TMEM94	9772	downregulated	Cisplatin results in decreased expression of TMEM94 mRNA	17q25.1	A20427
Cisplatin	Approved Investigational	TMTC2	160335	downregulated	Cisplatin results in decreased expression of TMTC2 mRNA	12q21.31	A22211 A20427
Cisplatin	Approved Investigational	TNF	7124	upregulated	Cisplatin results in increased expression of TNF mRNA	6p21.33	A22266
Cisplatin	Approved Investigational	TNFAIP8	25816	upregulated	Cisplatin results in increased expression of TNFAIP8 mRNA	5q23.1	A20427
Cisplatin	Approved Investigational	TNFRSF10A	8797	upregulated	Cisplatin results in increased expression of TNFRSF10A mRNA	8p21.3	A22212
Cisplatin	Approved Investigational	TNFRSF10B	8795	downregulated	Cisplatin results in decreased expression of TNFRSF10B mRNA	8p21.3	A21499
Cisplatin	Approved Investigational	TNFRSF10B	8795	upregulated	Cisplatin results in increased expression of TNFRSF10B mRNA	8p21.3	A22229 A22267 A22212 A20427
Cisplatin	Approved Investigational	TNFRSF10C	8794	upregulated	Cisplatin results in increased expression of TNFRSF10C mRNA	8p21.3	A22212
Cisplatin	Approved Investigational	TNFRSF10D	8793	upregulated	Cisplatin results in increased expression of TNFRSF10D mRNA	8p21.3	A22212
Cisplatin	Approved Investigational	TNFRSF11A	8792	upregulated	Cisplatin results in increased expression of TNFRSF11A mRNA	18q21.33	A22236
Cisplatin	Approved Investigational	TNFRSF18	8784	upregulated	Cisplatin results in increased expression of TNFRSF18 mRNA	1p36.33	A22236
Cisplatin	Approved Investigational	TNFRSF9	3604	upregulated	Cisplatin results in increased expression of TNFRSF9 mRNA	1p36.23	A22237
Cisplatin	Approved Investigational	TNFSF10	8743	upregulated	Cisplatin results in increased expression of TNFSF10 mRNA	3q26	A22229 A22266
Cisplatin	Approved Investigational	TNFSF13	8741	downregulated	Cisplatin results in decreased expression of TNFSF13 mRNA	17p13.1	A22268
Cisplatin	Approved Investigational	TNFSF9	8744	downregulated	Cisplatin results in decreased expression of TNFSF9 mRNA	19p13.3	A21499
Cisplatin	Approved Investigational	TNFSF9	8744	upregulated	Cisplatin results in increased expression of TNFSF9 mRNA	19p13.3	A22204 A20427
Cisplatin	Approved Investigational	TNS3	64759	downregulated	Cisplatin results in decreased expression of TNS3 mRNA	7p12.3	A22204 A22211
Cisplatin	Approved Investigational	TOB1	10140	upregulated	Cisplatin results in increased expression of TOB1 mRNA	17q21.33	A22204 A22212 A22203
Cisplatin	Approved Investigational	TOP1	7150	upregulated	Cisplatin results in increased expression of TOP1 mRNA	20q12	A20427
Cisplatin	Approved Investigational	TOP3A	7156	downregulated	Cisplatin results in decreased expression of TOP3A mRNA	17p11.2	A21499
Cisplatin	Approved Investigational	TOR1A	1861	downregulated	Cisplatin results in decreased expression of TOR1A mRNA	9q34.11	A21499
Cisplatin	Approved Investigational	TOX2	84969	downregulated	Cisplatin results in decreased expression of TOX2 mRNA	20q13.12	A22204
Cisplatin	Approved Investigational	TP53	7157	upregulated	Cisplatin results in increased expression of TP53 mRNA	17p13.1	A22084 A22214
Cisplatin	Approved Investigational	TP53I3	9540	upregulated	Cisplatin results in increased expression of TP53I3 mRNA	2p23.3	A22204 A22212 A22205 A20427
Cisplatin	Approved Investigational	TP53INP1	94241	upregulated	Cisplatin results in increased expression of TP53INP1 mRNA	8q22.1	A22204 A22212 A22205 A20427

Displaying entries 32126 - 32150 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability